Jeroen N. Stoop

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

Jerald Sadoff, Mathieu Le Gars, Georgi Shukarev et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text

Veterinary Medicine, Infectious Diseases, Immunization +16

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection†‡

Jeroen N. Stoop, Renate G. van der Molen, Carla C. Baan et al. · Hepatology · 2005 · 507 citations

Life Sciences, Immunology, Infectious Diseases +17

Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial

Jerald Sadoff, Mathieu Le Gars, Georgi Shukarev et al. · medRxiv · 2020 · 141 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Therapeutic effect of tolerogenic dendritic cells in established collagen‐induced arthritis is associated with a reduction in Th17 responses

Jeroen N. Stoop, Rachel A. Harry, Alexei von Delwig et al. · Arthritis & Rheumatism · 2010 · 136 citations

Life Sciences, Immunology, Pathology +17

Low-strength T-cell activation promotes Th17 responses

Harriet A. Purvis, Jeroen N. Stoop, Jelena Mann et al. · Blood · 2010 · 123 citations

Life Sciences, Cell Biology, Immunology +14